| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12185-008-0199-8 |
| P698 | PubMed publication ID | 19011769 |
| P2093 | author name string | Hui Xiao | |
| Bing Xia | |||
| Ke Jian Zhang | |||
| P2860 | cites work | Analysis of PALB2/FANCN-associated breast cancer families | Q24683771 |
| Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors | Q24791749 | ||
| CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin | Q24804759 | ||
| Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival | Q28188554 | ||
| Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors | Q28190640 | ||
| The emerging genetic and molecular basis of Fanconi anaemia | Q28199075 | ||
| The Fanconi anaemia/BRCA pathway | Q28201371 | ||
| A novel ubiquitin ligase is deficient in Fanconi anemia | Q28206919 | ||
| Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer | Q28260207 | ||
| Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype | Q28296642 | ||
| Biallelic inactivation of BRCA2 in Fanconi anemia | Q29616130 | ||
| Hallmarks of 'BRCAness' in sporadic cancers | Q29618825 | ||
| Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method | Q33965225 | ||
| Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes | Q34278200 | ||
| Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer | Q34597168 | ||
| Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. | Q34597176 | ||
| Functional defects in the fanconi anemia pathway in pancreatic cancer cells | Q35102998 | ||
| FANCF methylation contributes to chemoselectivity in ovarian cancer | Q35142957 | ||
| Tracing the network connecting BRCA and Fanconi anaemia proteins | Q35730286 | ||
| The Fanconi anemia pathway limits the severity of mutagenesis | Q36525081 | ||
| Fanconi anaemia genes and susceptibility to cancer | Q36602573 | ||
| The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells | Q40440435 | ||
| Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia | Q40616526 | ||
| The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J | Q55671102 | ||
| Fanconi anemia gene mutations in young-onset pancreatic cancer | Q73400804 | ||
| Lymphoblastic lymphoma and excessive toxicity from chemotherapy: an unusual presentation for Fanconi anemia | Q77860702 | ||
| Germ line Fanconi anemia complementation group C mutations and pancreatic cancer | Q81369409 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 543-550 | |
| P577 | publication date | 2008-11-15 | |
| P1433 | published in | International Journal of Hematology | Q6051416 |
| P1476 | title | Defects of FA/BRCA pathway in lymphoma cell lines | |
| P478 | volume | 88 |
| Q27913808 | Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection |
| Q37415432 | Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes |
| Q40063188 | The Role of PALB2 in the DNA Damage Response and Cancer Predisposition. |
Search more.